Quadrature Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $90.9M | Buy |
75,764
+8,767
| +13% | +$8.96M | 0.78% | 31 |
|
|
2026
Q1 | $61.6M | Sell |
66,997
-148,867
| -69% | -$151M | 0.73% | 29 |
|
|
2025
Q4 | $232M | Buy |
215,864
+100,000
| +86% | +$95.6M | 2.37% | 4 |
|
|
2025
Q3 | $88.3M | Buy |
+115,864
| New | +$86.2M | 1.04% | 25 |
|
|
2025
Q1 | – | Sell |
-52,038
| Closed | -$40.2M | – | 1311 |
|
|
2024
Q4 | $40.2M | Sell |
52,038
-41,593
| -44% | -$34.4M | 0.81% | 22 |
|
|
2024
Q3 | $82.9M | Buy |
+93,631
| New | +$84.2M | 1.88% | 14 |
|
|
2023
Q4 | – | Sell |
-53,260
| Closed | -$28.6M | – | 1278 |
|
|
2023
Q3 | $28.6M | Sell |
53,260
-59,613
| -53% | -$30.7M | 0.59% | 41 |
|
|
2023
Q2 | $52.9M | Buy |
112,873
+78,279
| +226% | +$32.8M | 1.16% | 16 |
|
|
2023
Q1 | $11.9M | Buy |
+34,594
| New | +$11.7M | 0.33% | 78 |
|
|
2022
Q1 | – | Sell |
-33,903
| Closed | -$9.36M | – | 854 |
|
|
2021
Q4 | $9.36M | Buy |
33,903
+5,532
| +19% | +$1.4M | 0.49% | 45 |
|
|
2021
Q3 | $6.55M | Buy |
+28,371
| New | +$7M | 0.24% | 75 |
|
|
2021
Q1 | – | Sell |
-6,963
| Closed | -$1.18M | – | 1028 |
|
|
2020
Q4 | $1.18M | Sell |
6,963
-119,262
| -94% | -$17.8M | 0.06% | 269 |
|
|
2020
Q3 | $18.7M | Buy |
126,225
+93,421
| +285% | +$14.5M | 1.07% | 8 |
|
|
2020
Q2 | $5.38M | Buy |
+32,804
| New | +$5.04M | 0.61% | 30 |
|
|
2019
Q4 | – | Sell |
-47,916
| Closed | -$5.36M | – | 623 |
|
|
2019
Q3 | $5.36M | Buy |
+47,916
| New | +$5.33M | 0.26% | 107 |
|
|
2018
Q4 | – | Sell |
-19,411
| Closed | -$2.08M | – | 587 |
|
|
2018
Q3 | $2.08M | Sell |
19,411
-77,348
| -80% | -$7.73M | 0.17% | 139 |
|
|
2018
Q2 | $8.26M | Buy |
+96,759
| New | +$7.95M | 0.77% | 29 |
|
|
2018
Q1 | – | Sell |
-108,106
| Closed | -$9.14M | – | 680 |
|
|
2017
Q4 | $9.14M | Buy |
+108,106
| New | +$9.2M | 0.81% | 26 |
|
|
2017
Q3 | – | Sell |
-4,346
| Closed | -$358K | – | 539 |
|
|
2017
Q2 | $358K | Buy |
+4,346
| New | +$355K | 0.03% | 420 |
|
|
2017
Q1 | – | Sell |
-13,754
| Closed | -$1.01M | – | 766 |
|
|
2016
Q4 | $1.01M | Sell |
13,754
-117,476
| -90% | -$8.75M | 0.03% | 427 |
|
|
2016
Q3 | $10.5M | Sell |
131,230
-30,549
| -19% | -$2.45M | 0.92% | 20 |
|
|
2016
Q2 | $12.7M | Buy |
+161,779
| New | +$12.2M | 0.95% | 20 |
|
|
2016
Q1 | – | Sell |
-32,230
| Closed | -$2.71M | – | 518 |
|
|
2015
Q4 | $2.71M | Buy |
+32,230
| New | +$2.67M | 0.42% | 56 |
|
|
2015
Q3 | – | Sell |
-5,099
| Closed | -$426K | – | 301 |
|
|
2015
Q2 | $426K | Buy |
+5,099
| New | +$389K | 0.38% | 81 |
|
|
2015
Q1 | – | Sell |
-4,200
| Closed | -$290K | – | 127 |
|
|
2014
Q4 | $290K | Buy |
+4,200
| New | +$283K | 1.07% | 43 |
|
Other funds holding LLY
Quadrature Capital's LLY Position: Q2 2026 in Review
Quadrature Capital increased its Eli Lilly (LLY) stake by 13% in Q2 2026, buying an estimated $8.96M and bringing the position to 75,764 shares worth $90.9M. The position accounts for 0.78% of the portfolio, ranked #31.
Quadrature Capital first reported a position in LLY in Q4 2014 and has held it in 25 quarters since. The position peaked at $232M in Q4 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Quadrature Capital held 75,764 shares of Eli Lilly worth $90.9M as of Q2 2026.
- Quadrature Capital bought 8,767 Eli Lilly shares in Q2 2026, an estimated $8.96M.
- Eli Lilly made up 0.78% of Quadrature Capital's portfolio in Q2 2026, its #31 holding.
- Quadrature Capital first reported a position in Eli Lilly in Q4 2014 and has held it in 25 quarters since.
- Quadrature Capital's Eli Lilly position peaked at $232M in Q4 2025.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.